New endoscopy method may spot stomach cancer earlier

NCT ID NCT02738294

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a special endoscopy technique called ME-NBI (magnifying endoscopy with narrow band imaging) can better diagnose early stomach cancer than the standard white light biopsy. Researchers looked at 211 patients with suspicious stomach lesions. They compared the accuracy of ME-NBI targeted biopsy against standard forceps biopsy, using final surgical specimens as the gold standard.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ME-NBI (magnifying endoscopy with narrow band imaging) device
What this could lead to
If successful, this could show that ME-NBI targeted biopsy is more accurate than standard white light biopsy for diagnosing early gastric cancer, potentially reducing unnecessary biopsies.
What could go wrong
This is a completed study with 211 participants, so results are available but may not apply to all patients or settings. The technique requires specialized equipment and training.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Departments of Gastroenterology and Clinical Laboratory, Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine

    Shanghai, 200001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.